TY - JOUR
T1 - A novel approach to left atrial appendage exclusion
T2 - The WATCHMAN device
AU - Gorodnitskiy, Alexander
AU - Lucariello, Richard J.
AU - Aizer, Anthony
AU - Coppola, John T.
PY - 2010/9
Y1 - 2010/9
N2 - Atrial fibrillation (AF), a very common cardiac arrhythmia, is a well-recognized predisposing factor for embolic stroke. While warfarin remains the cornerstone of anticoagulant treatment in patients with AF, it is often underutilized because of increased bleeding complications and frequent monitoring requirements. It has been documented that the left atrial appendage (LAA) is the main source of left atrial thrombus that causes strokes in AF patients. Thus, closure of the LAA may be an effective strategy in stroke reduction. Several devices have been used in closure of the LAA. The WATCHMAN device appears to be a safe and efficacious device for closure of the LAA as recently demonstrated in the PROTECT AF trial.
AB - Atrial fibrillation (AF), a very common cardiac arrhythmia, is a well-recognized predisposing factor for embolic stroke. While warfarin remains the cornerstone of anticoagulant treatment in patients with AF, it is often underutilized because of increased bleeding complications and frequent monitoring requirements. It has been documented that the left atrial appendage (LAA) is the main source of left atrial thrombus that causes strokes in AF patients. Thus, closure of the LAA may be an effective strategy in stroke reduction. Several devices have been used in closure of the LAA. The WATCHMAN device appears to be a safe and efficacious device for closure of the LAA as recently demonstrated in the PROTECT AF trial.
UR - http://www.scopus.com/inward/record.url?scp=77955874047&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77955874047&partnerID=8YFLogxK
U2 - 10.1097/CRD.0b013e3181e53abb
DO - 10.1097/CRD.0b013e3181e53abb
M3 - Review article
C2 - 20699670
AN - SCOPUS:77955874047
SN - 1061-5377
VL - 18
SP - 230
EP - 233
JO - Cardiology in review
JF - Cardiology in review
IS - 5
ER -